JUPITER-02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps

Cancer Commun (Lond). 2022 Jan;42(1):56-59. doi: 10.1002/cac2.12248. Epub 2021 Dec 16.
No abstract available